Home MannKind Price Target Cut to $4.00 by Analysts at MLV & Co.
 

Keywords :   


MannKind Price Target Cut to $4.00 by Analysts at MLV & Co.

2015-05-18 04:16:11| Biotech - Topix.net

The firm currently has a "hold" rating on the stock. MLV & Co.' s price target would suggest a potential upside of 0.13% from the company's current price.

Tags: co price cut target

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Public Advisory Number 18A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07Atlantic Tropical Weather Outlook
03.07Benefits of benchmarking in the pork industry
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 18
More »